CD2 and periodontitis: An anti-inflammatory effect of Lactobacillus brevis CD2 administered to a group of patients with chronic periodontitis was reported and related to the capacity of the probiotic to prevent the production of nitric oxide and, consequently, the release of PGE2 and the activation of MMPs induced by the nitric oxide [34].